| ID | 1595 |
|---|
| No | 1595 |
|---|
| Brand Name | ALIEMPAGLIFLOZIN + ALILINAGLIPTIN |
|---|
| Ingredients | EMPAGLIFLOZIN 10 MG, LINAGLIPTIN 5 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 2 X 7'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | WHITE FILM COATED TABLET |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 08 L 1176/24 |
|---|
| FDD Registration Date | 28/08/2024 |
|---|
| Expiry Date | 27/08/2027 |
|---|
